575 related articles for article (PubMed ID: 3088026)
21. Neuroendocrine responses to a novel growth hormone secretagogue, L-692,429, in healthy older subjects.
Aloi JA; Gertz BJ; Hartman ML; Huhn WC; Pezzoli SS; Wittreich JM; Krupa DA; Thorner MO
J Clin Endocrinol Metab; 1994 Oct; 79(4):943-9. PubMed ID: 7962302
[TBL] [Abstract][Full Text] [Related]
22. The decrease in growth hormone (GH) response after repeated stimulation with GH-releasing hormone is partly caused by an elevation of somatostatin tonus.
Reichardt B; Schrader M; Mojto J; Mehltretter G; Müller OA; Schopohl J
J Clin Endocrinol Metab; 1996 May; 81(5):1994-8. PubMed ID: 8626871
[TBL] [Abstract][Full Text] [Related]
23. The higher the growth hormone response to growth hormone releasing hormone the lower the response to bromocriptine and thyrotrophin releasing hormone in acromegaly.
Smals AE; Pieters GF; Smals AG; Hermus AR; Benraad TJ; Kloppenborg PW
Clin Endocrinol (Oxf); 1987 Jul; 27(1):43-7. PubMed ID: 3115634
[TBL] [Abstract][Full Text] [Related]
24. Growth hormone responses to continuous infusions of growth hormone-releasing hormone.
Gelato MC; Rittmaster RS; Pescovitz OH; Nicoletti MC; Nixon WE; D'Agata R; Loriaux DL; Merriam GR
J Clin Endocrinol Metab; 1985 Aug; 61(2):223-8. PubMed ID: 3924946
[TBL] [Abstract][Full Text] [Related]
25. Lack of in vivo somatotroph desensitization or depletion after 14 days of continuous growth hormone (GH)-releasing hormone administration in normal men and a GH-deficient boy.
Vance ML; Kaiser DL; Martha PM; Furlanetto R; Rivier J; Vale W; Thorner MO
J Clin Endocrinol Metab; 1989 Jan; 68(1):22-8. PubMed ID: 2491864
[TBL] [Abstract][Full Text] [Related]
26. Growth hormone-releasing factor increases serum prolactin concentrations in normal subjects and in patients with pituitary adenomas.
Serri O; Somma M; Rasio E; Brazeau P
Clin Endocrinol (Oxf); 1989 Jan; 30(1):65-75. PubMed ID: 2505955
[TBL] [Abstract][Full Text] [Related]
27. Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone.
Arvat E; Maccario M; Di Vito L; Broglio F; Benso A; Gottero C; Papotti M; Muccioli G; Dieguez C; Casanueva FF; Deghenghi R; Camanni F; Ghigo E
J Clin Endocrinol Metab; 2001 Mar; 86(3):1169-74. PubMed ID: 11238504
[TBL] [Abstract][Full Text] [Related]
28. Cholinergic involvement in the growth hormone releasing hormone-induced growth hormone release: studies in normal and acromegalic subjects.
Massara F; Ghigo E; Demislis K; Tangolo D; Mazza E; Locatelli V; Müller EE; Molinatti GM; Camanni F
Neuroendocrinology; 1986; 43(6):670-5. PubMed ID: 3093909
[TBL] [Abstract][Full Text] [Related]
29. Impaired inhibitory effects of somatostatin on growth hormone (GH)-releasing hormone stimulation of GH secretion after short term infusion.
Kelijman M; Frohman LA
J Clin Endocrinol Metab; 1990 Jul; 71(1):157-63. PubMed ID: 1973420
[TBL] [Abstract][Full Text] [Related]
30. Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion.
Alba-Roth J; Müller OA; Schopohl J; von Werder K
J Clin Endocrinol Metab; 1988 Dec; 67(6):1186-9. PubMed ID: 2903866
[TBL] [Abstract][Full Text] [Related]
31. Contribution of growth hormone-releasing hormone and somatostatin to decreased growth hormone secretion in elderly men.
Soule SG; Macfarlane P; Levitt NS; Millar RP
S Afr Med J; 2001 Mar; 91(3):254-60. PubMed ID: 11291426
[TBL] [Abstract][Full Text] [Related]
32. The effects of acute and chronic growth hormone (GH) administration on GH secretion in patients with idiopathic GH deficiency.
Hanew K; Goh M; Sato S; Shimizu Y; Sasaki A; Aida M; Yoshinaga K
J Clin Endocrinol Metab; 1988 Apr; 66(4):715-21. PubMed ID: 3126213
[TBL] [Abstract][Full Text] [Related]
33. Corticotropin-releasing hormone inhibition of growth hormone-releasing hormone-induced growth hormone release in man.
Barbarino A; Corsello SM; Della Casa S; Tofani A; Sciuto R; Rota CA; Bollanti L; Barini A
J Clin Endocrinol Metab; 1990 Nov; 71(5):1368-74. PubMed ID: 2229294
[TBL] [Abstract][Full Text] [Related]
34. Long-term treatment of acromegaly with Sandostatin (SMS 201-995). Normalization of most anomalous growth hormone responses.
Pieters GF; van Liessum PA; Smals AG; van Gennep JA; Benraad TJ; Kloppenborg PW
Acta Endocrinol Suppl (Copenh); 1987; 286():9-18. PubMed ID: 2892339
[TBL] [Abstract][Full Text] [Related]
35. Nitric oxide modulates in vivo and in vitro growth hormone release in acromegaly.
Cuttica CM; Giusti M; Bocca L; Sessarego P; De Martini D; Valenti S; Spaziante R; Giordano G
Neuroendocrinology; 1997 Dec; 66(6):426-31. PubMed ID: 9430448
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of selective transsphenoidal adenomectomy by endocrinological testing and somatomedin-C measurement in acromegaly.
Losa M; Oeckler R; Schopohl J; Müller OA; Alba-Lopez J; von Werder K
J Neurosurg; 1989 Apr; 70(4):561-7. PubMed ID: 2647918
[TBL] [Abstract][Full Text] [Related]
37. Failure to respond to growth hormone releasing hormone (GHRH) in acromegaly due to a GHRH secreting pancreatic tumor: dynamics of multiple endocrine testing.
Schulte HM; Benker G; Windeck R; Olbricht T; Reinwein D
J Clin Endocrinol Metab; 1985 Sep; 61(3):585-7. PubMed ID: 3926812
[TBL] [Abstract][Full Text] [Related]
38. Human pancreatic growth hormone-releasing factor (hpGRF-44) in acromegaly before and after adenomectomy. Modifications induced by somatostatin (GHRIH) infusion.
Arosio M; Ambrosi B; Guglielmino L; Faglia G
J Endocrinol Invest; 1985 Oct; 8(5):449-53. PubMed ID: 2867112
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the sensitivity of growth hormone secretion to somatostatin in vivo and in vitro in acromegaly.
Kelijman M; Williams TC; Downs TR; Frohman LA
J Clin Endocrinol Metab; 1988 Nov; 67(5):958-63. PubMed ID: 2903171
[TBL] [Abstract][Full Text] [Related]
40. Effect of acute pharmacological modulation of plasma free fatty acids on GH secretion in acromegalic patients.
Cordido F; Peñalva A; Martinez T; Casanueva FF; Dieguez C
Clin Endocrinol (Oxf); 2001 Apr; 54(4):509-13. PubMed ID: 11318787
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
